RxDoctor Payments Data

Ahmed Al Badri, MD

Interventional Cardiology · Marietta, GANPI 1336406958

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (59.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Boston Scientific at 50.0% of the total. Reporting peaked in 2022 at $73,103 and has fallen 71.0% since, to $21,204 in 2025. Among interventional cardiology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$109,554in general payments, 2019–2025

Across 460 payments — averaging $238.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$55K
  • Edwards Lifesciences$22K
  • Medtronic$18K
  • Penumbra, Inc.$4K
  • Abiomed$4K
  • Abbott$3K
  • plus $4K from 16 others

What the payments were for

  • Consulting fees$7,6857%
  • Speaking & faculty fees$1,2001%
  • Grants$65,25060%
  • Travel & lodging$10,2209%
  • Food & beverage$25,19923%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$109,554 in reported general payments places this provider in the 90th percentile of 218 interventional cardiology providers in Georgia.

See all interventional cardiology providers in Georgia

Medicare billing

Part B allowed, 2024
$211,544
Medicare patients
534
Services billed
1,016

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban22$16,589
BrilintaTicagrelor17$9,870
Atorvastatin Calcium43$437
ClopidogrelClopidogrel Bisulfate36$349
Metoprolol Succinate31$269
Lisinopril15$95
Amlodipine Besylate18$86

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →